VectorY Therapeutics: VectorY Announces Participation in Scientific Conferences in October 2022

VectorY Therapeutics, a biotech company focusing on the development of innovative gene therapy approaches for the treatment of neuro-degenerative and muscular disorders through vectorized antibodies

Related Keywords

Amsterdam ,Noord Holland ,Netherlands ,Kostenloser Wertpapierhandel ,Andreia Duarte ,Pavlina Konstantinova ,Hilde Van Tongeren ,Sariette Witte ,Barbara Sanders ,Carmen Gallego ,Head Of Communications ,Research Symposium ,European Society Of Gene Cell Therapy ,Vectory Therapeutics ,Amyotrophic Lateral Sclerosis ,Chief Scientific Officer ,Gene Cell Therapy ,Annual Congress ,Menno Spits ,Poster Session ,Vector Generation ,Vector Technologies ,Gene Meeting ,Chief Technology Officer ,Amsterdam Science ,Manisha Kuttetira ,Vectory ,Herapeutics ,Nnounces ,Participation ,Cientific ,Conferences ,October ,022 ,